NS
Narang Singh
About Narang Singh
Data last updated:
Narang Singh was a Director at Health Scope Remedies Private Limited (2018–2023), Director at Zenlabs Ethica Limited (2009–2019) and Director at Quixotic Pharma Private Limited (2002–2018), and held 2 more directorships. The companies operate in Pharma and Financial Services.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 May 2018 | 2018 | ₹10.43 Cr (FY 2024) | Active | |
| Director | 20 Mar 2009 | 1993 | ₹51.47 Cr (FY 2025) | Active | |
| Director | 29 Nov 2002 | 2002 | ₹27.58 Cr (FY 2025) | Active | |
| Director | 30 Sep 2005 | 1993 | ₹6.09 Cr (FY 2025) | Active | |
| Director | 20 Feb 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narang Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narang Singh
Narang Singh was first appointed on 29 Nov 2002 as Director at Quixotic Pharma Private Limited. The most recent appointment on record is 20 Feb 2021 at Gredissons Private Limited.
Narang Singh held 5 earlier board appointments: Health Scope Remedies Private Limited (Director, 09 May 2018 to 01 Apr 2023); Zenlabs Ethica Limited (Director, 20 Mar 2009 to 01 Apr 2019); Quixotic Pharma Private Limited (Director, 29 Nov 2002 to 23 Mar 2018); Ultra Chiron Pharmaceuticals Pvt Ltd (Director, 30 Sep 2005 to 23 Mar 2018); Gredissons Private Limited (Director, from 20 Feb 2021).